Results 41 to 50 of about 3,761,140 (303)

Diagnosis of human cytomegvirus association with malignant gliomas and pro- and anti-inflammatories

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2020
The study was conducted on seventy individuals of both genders who have been exposed to human cytomegalovirus, a common illness in Iraq. Total cases of human cytomegvirus associated with malignant brain tumors were detected by a real time PCR technique ...
Alameedy Fadyia Mahdi Muslim   +1 more
doaj   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

APPLICATION OF CHI SQUARE TEST IN MARKETING RESEARCH [PDF]

open access: yesAnnals of the University of Petrosani: Economics, 2017
The paper brings into focus the usefulness of chi square test in the field of marketing research. A chi square test represents a statistical tool based on the chi-square distribution of probability, which is easy to apply by a non-mathematician ...
CODRUȚA DURA, IMOLA DRIGĂ
doaj  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Statistical analysis of the relation between human age and gender on the risk of death from cancer in head and neck CT-Scan [PDF]

open access: yesمجله علوم و فنون هسته‌ای
The purpose of this study was to investigate the effects of human age and gender on the estimation of the death risk due to cancer in head and neck CT scans.
R. Ahangari, M. Abdolalizadeh
doaj   +1 more source

Cómo aplicar un cluster jerárquico en SPSS [PDF]

open access: yes, 2015
L'anàlisi de conglomerats o cluster és una tècnica multivariant que busca agrupar elements o variables tractant d'aconseguir la màxima homogeneïtat en cada grup i la major diferència entre ells, mitjançant una estructura jerarquitzada per poder decidir ...
Berlanga, Vanessa   +3 more
core  

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Impact of Strategic Planning on Organizational Performance and Survival [PDF]

open access: yes, 2010
The study examined the impact of strategic planning on organizational performance and survival. The effectiveness of strategic planning can be measured in terms of the extent to which it influences organizational performance, which affects its survival ...
Akinyele, S.T., Fasogbon, O.I.
core  

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy